European Union suspends Pfizer's Oxbryta for sickle cell disease due to safety concerns, urging doctors to stop use ...

"We are excited to partner with BeiGene to investigate this promising combination therapy," said John Hsu, CEO of Anbogen. "ABT-301 has shown potential in preclinical studies, and we believe that ...

I can’t be the only one confused by collagen in beauty products ...

Specific combinations of hormonal and biochemical factors were associated with different clinical characteristics and ...

In a report released today, Roy Buchanan from JMP Securities reiterated a Buy rating on Enanta Pharmaceuticals (ENTA – Research Report), ...

Ashwagandha is a popular herbal supplement for stress and sleep. What does the science say? Experts discuss ashwagandha uses, ...

Glioblastoma is the most common and most aggressive primary brain tumour, with an average survival after diagnosis of less ...

Results of the human clinical trial will be shared with LifeVantage Consultants at Market Connect in Kansas City, October ...

Annovis Bio saw promising results for Buntanetap in treating Alzheimer's and Parkinson's, but short cash runway prompts a ...

Stroke related to large vessel occlusion (LVO) is a leading cause of disability and death worldwide. Endovascular therapy (minimally invasive procedures like catheterization done inside the blood ...

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

Prostate cancer disproportionately affects Black men, leading to higher mortality rates and worse health outcomes compared to ...